fundvisualizer.com

BNY Mellon Intl Eq Income MMLIMX

Performance (before sales charge)

As of 01/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2023
Stock
0.00%
Non-U.S. Stock
100.32%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
-0.32%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2023

Basic materials

7.80%

Consumer cyclical

11.06%

Financial services

23.21%

Real estate

0.21%

Consumer defensive

6.22%

Health care

8.12%

Utilities

3.92%

Communication services

6.98%

Energy

6.19%

Industrials

10.70%

Technology

15.70%

Top 10 holdings

As of 12/31/2023

Wesfarmers Ltd
2.94%
AXA SA
2.77%
SUMCO Corp
2.29%
Spark New Zealand Ltd
2.14%
Us Dollar
2.13%
Takeda Pharmaceutical Co Ltd
1.99%
Imperial Brands PLC
1.98%
CEZ a.s
1.97%
Eni SpA
1.92%
Swiss Re AG
1.83%
Fund assets

$19.1 Million

Share class

M

Morningstar category

Foreign Large Value

Expense ratio

1.62%

Investment objective

Foreign Stock

Documents
    Compare against similar funds*

    * “Similar funds” are top 10 performing funds in the same Morningstar category and share class , defaulted to 5 Year at NAV.